The COVID-19 pandemic shoved the nation’s weak supply of personal protective equipment into the limelight when hospitals scrambled to grab enough gowns, medical masks and gloves in 2020. More than two years later, N95 respirator masks exited the FDA’s …
With some hospitals and health systems spending up to 40 percent of their budgets on supply, consulting company McKinsey compiled supply chain executives’ main strategies at bolstering their work and published the results Aug. 23.
The latest strategy to stretch the supply of the world’s only monkeypox vaccine, Bavarian Nordic’s Jynneos, is frustrating local health officials tasked with distributing the doses, Politico reported Aug. 24.
Here are supply chain updates that have been reported by Becker’s since Aug. 16:
Here are five recent acquisitions, deals and partnerships that have sprung up since Aug. 16:
Vitalant’s blood supply has dropped by nearly 50 percent since early summer, the supplier said Aug. 22, urging people to donate ahead of Labor Day weekend.
An additional 1.8 million doses of the Jynneos monkeypox vaccine will be available for health departments to order starting Aug. 22, according to White House officials.
Devicemaker InnAVasc medical was acquired by W.L. Gore & Associates, maker of Gore-Tex, WRAL reported Aug. 18.
As monkeypox vaccine supply wanes, members of Congress from New York called on the Biden Administration Aug. 16 to invoke the Defense Protection Act, which they say would ramp up domestic production.
With a $170 million deal, UNICEF will acquire 18 million malaria vaccines from GSK, a global pharmaceutical company based in London.
